163 related articles for article (PubMed ID: 8338875)
1. Mdx transgenic mouse: restoration of recombinant dystrophin to the dystrophic muscle.
Lee CC; Pons F; Jones PG; Bies RD; Schlang AM; Leger JJ; Caskey CT
Hum Gene Ther; 1993 Jun; 4(3):273-81. PubMed ID: 8338875
[TBL] [Abstract][Full Text] [Related]
2. Efficiency and functional consequences of adenovirus-mediated in vivo gene transfer to normal and dystrophic (mdx) mouse diaphragm.
Petrof BJ; Acsadi G; Jani A; Massie B; Bourdon J; Matusiewicz N; Yang L; Lochmüller H; Karpati G
Am J Respir Cell Mol Biol; 1995 Nov; 13(5):508-17. PubMed ID: 7576685
[TBL] [Abstract][Full Text] [Related]
3. Long-term effect of human mini-dystrophin in transgenic mdx mice improves muscle physiological function.
Chu X; Li J; Qiao C; Wang J; Wang Y; Jiang XC; You H; Xiao X; Wang B
FASEB J; 2021 Jun; 35(6):e21628. PubMed ID: 33982338
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of dystrophin in transgenic mdx mice eliminates dystrophic symptoms without toxicity.
Cox GA; Cole NM; Matsumura K; Phelps SF; Hauschka SD; Campbell KP; Faulkner JA; Chamberlain JS
Nature; 1993 Aug; 364(6439):725-9. PubMed ID: 8355788
[TBL] [Abstract][Full Text] [Related]
5. Dystrophin deficiency in canine X-linked muscular dystrophy in Japan (CXMDJ) alters myosin heavy chain expression profiles in the diaphragm more markedly than in the tibialis cranialis muscle.
Yuasa K; Nakamura A; Hijikata T; Takeda S
BMC Musculoskelet Disord; 2008 Jan; 9():1. PubMed ID: 18182116
[TBL] [Abstract][Full Text] [Related]
6. Autologous transplantation of muscle precursor cells modified with a lentivirus for muscular dystrophy: human cells and primate models.
Quenneville SP; Chapdelaine P; Skuk D; Paradis M; Goulet M; Rousseau J; Xiao X; Garcia L; Tremblay JP
Mol Ther; 2007 Feb; 15(2):431-8. PubMed ID: 17235323
[TBL] [Abstract][Full Text] [Related]
7. Human dystrophin expression corrects the myopathic phenotype in transgenic mdx mice.
Wells DJ; Wells KE; Walsh FS; Davies KE; Goldspink G; Love DR; Chan-Thomas P; Dunckley MG; Piper T; Dickson G
Hum Mol Genet; 1992 Apr; 1(1):35-40. PubMed ID: 1301134
[TBL] [Abstract][Full Text] [Related]
8. The mouse dystrophin muscle promoter/enhancer drives expression of mini-dystrophin in transgenic mdx mice and rescues the dystrophy in these mice.
Anderson CL; De Repentigny Y; Cifelli C; Marshall P; Renaud JM; Worton RG; Kothary R
Mol Ther; 2006 Nov; 14(5):724-34. PubMed ID: 16807118
[TBL] [Abstract][Full Text] [Related]
9. Smooth muscle-specific dystrophin expression improves aberrant vasoregulation in mdx mice.
Ito K; Kimura S; Ozasa S; Matsukura M; Ikezawa M; Yoshioka K; Ueno H; Suzuki M; Araki K; Yamamura K; Miwa T; Dickson G; Thomas GD; Miike T
Hum Mol Genet; 2006 Jul; 15(14):2266-75. PubMed ID: 16777842
[TBL] [Abstract][Full Text] [Related]
10. Distribution of dystrophin and neurofilament protein in muscle spindles of normal and Mdx-dystrophic mice: an immunocytochemical study.
Nahirney PC; Ovalle WK
Anat Rec; 1993 Apr; 235(4):501-10. PubMed ID: 8465985
[TBL] [Abstract][Full Text] [Related]
11. The frequency of revertants in mdx mouse genetic models for Duchenne muscular dystrophy.
Danko I; Chapman V; Wolff JA
Pediatr Res; 1992 Jul; 32(1):128-31. PubMed ID: 1635838
[TBL] [Abstract][Full Text] [Related]
12. Myotubes from transgenic mdx mice expressing full-length dystrophin show normal calcium regulation.
Denetclaw WF; Hopf FW; Cox GA; Chamberlain JS; Steinhardt RA
Mol Biol Cell; 1994 Oct; 5(10):1159-67. PubMed ID: 7865881
[TBL] [Abstract][Full Text] [Related]
13. Ex vivo gene transfer using adenovirus-mediated full-length dystrophin delivery to dystrophic muscles.
Floyd SS; Clemens PR; Ontell MR; Kochanek S; Day CS; Yang J; Hauschka SD; Balkir L; Morgan J; Moreland MS; Feero GW; Epperly M; Huard J
Gene Ther; 1998 Jan; 5(1):19-30. PubMed ID: 9536261
[TBL] [Abstract][Full Text] [Related]
14. Electrotransfer of the full-length dog dystrophin into mouse and dystrophic dog muscles.
Pichavant C; Chapdelaine P; Cerri DG; Bizario JC; Tremblay JP
Hum Gene Ther; 2010 Nov; 21(11):1591-601. PubMed ID: 20553115
[TBL] [Abstract][Full Text] [Related]
15. Transient immunosuppression by FK506 permits a sustained high-level dystrophin expression after adenovirus-mediated dystrophin minigene transfer to skeletal muscles of adult dystrophic (mdx) mice.
Lochmüller H; Petrof BJ; Pari G; Larochelle N; Dodelet V; Wang Q; Allen C; Prescott S; Massie B; Nalbantoglu J; Karpati G
Gene Ther; 1996 Aug; 3(8):706-16. PubMed ID: 8854096
[TBL] [Abstract][Full Text] [Related]
16. Systemic delivery of morpholino oligonucleotide restores dystrophin expression bodywide and improves dystrophic pathology.
Alter J; Lou F; Rabinowitz A; Yin H; Rosenfeld J; Wilton SD; Partridge TA; Lu QL
Nat Med; 2006 Feb; 12(2):175-7. PubMed ID: 16444267
[TBL] [Abstract][Full Text] [Related]
17. PDGF-receptor concentration is elevated in regenerative muscle fibers in dystrophin-deficient muscle.
Tidball JG; Spencer MJ; St Pierre BA
Exp Cell Res; 1992 Nov; 203(1):141-9. PubMed ID: 1426037
[TBL] [Abstract][Full Text] [Related]
18. Expression of full-length and truncated dystrophin mini-genes in transgenic mdx mice.
Phelps SF; Hauser MA; Cole NM; Rafael JA; Hinkle RT; Faulkner JA; Chamberlain JS
Hum Mol Genet; 1995 Aug; 4(8):1251-8. PubMed ID: 7581361
[TBL] [Abstract][Full Text] [Related]
19. Prevention of dystrophic pathology in mdx mice by a truncated dystrophin isoform.
Rafael JA; Sunada Y; Cole NM; Campbell KP; Faulkner JA; Chamberlain JS
Hum Mol Genet; 1994 Oct; 3(10):1725-33. PubMed ID: 7849695
[TBL] [Abstract][Full Text] [Related]
20. Revertant fibres: a possible genetic therapy for Duchenne muscular dystrophy?
Wilton SD; Dye DE; Blechynden LM; Laing NG
Neuromuscul Disord; 1997 Jul; 7(5):329-35. PubMed ID: 9267847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
